Article Details
Retrieved on: 2020-01-01 20:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>ValuEngine upgraded shares of Aridis Pharmaceuticals (NASDAQ:ARDS) from a buy rating to a strong-buy rating in a research note published on ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here